CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,799 | -52.1% | 17,427 | -60.9% | 0.00% | -50.0% |
| Q2 2023 | $991,816 | +9.0% | 44,576 | +6.1% | 0.00% | 0.0% |
| Q1 2023 | $910,045 | +15.8% | 42,015 | +8.6% | 0.00% | +33.3% |
| Q4 2022 | $785,794 | -18.5% | 38,690 | +2.9% | 0.00% | -40.0% |
| Q3 2022 | $964,000 | +9.7% | 37,601 | +1.7% | 0.01% | +25.0% |
| Q2 2022 | $879,000 | +16.3% | 36,981 | +10.1% | 0.00% | +33.3% |
| Q1 2022 | $756,000 | +0.9% | 33,591 | -11.1% | 0.00% | 0.0% |
| Q4 2021 | $749,000 | -40.4% | 37,806 | -40.8% | 0.00% | -50.0% |
| Q3 2021 | $1,257,000 | -0.7% | 63,874 | +11.0% | 0.01% | 0.0% |
| Q2 2021 | $1,266,000 | +88.1% | 57,559 | +103.4% | 0.01% | +100.0% |
| Q1 2021 | $673,000 | -1.2% | 28,301 | +8.7% | 0.00% | -25.0% |
| Q4 2020 | $681,000 | -17.8% | 26,043 | -45.3% | 0.00% | -20.0% |
| Q3 2020 | $828,000 | +441.2% | 47,583 | +423.9% | 0.01% | +400.0% |
| Q2 2020 | $153,000 | – | 9,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |